EuroPCR 2022: ALIGN-EFS Finds 100% Procedural Success Rate Using JenaValve Trilogy in Pts With AS

Published: 23 May 2022

  • Views:

    Views Icon 68
  • Likes:

    Heart Icon 0

In this short interview, Dr Matti Adam (University Hospital Cologne, DE) outlines the findings of the ALIGN-AS EFS trial (NCT02732691). This study aimed to evaluate the clinical efficacy of the JenaValve TAVR System in patients with severe aortic stenosis. The findings show a 100% procedural success rate.

Discussion points:
1. Aim of This Study
2. JenaValve TAVR System
3. Study Design and Patient Population
4. Key Findings
5. Take-Home Messages
6. Next Steps

Recorded remotely from Cologne, 2022.
Interviewer: Jordan Rance